PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 208 filers reported holding PACIRA PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 0.87 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $51,548,000 | -31.1% | 671,287 | -63.1% | 0.04% | +29.4% |
| Q3 2015 | $74,782,000 | -67.8% | 1,819,516 | -44.6% | 0.03% | -82.2% |
| Q2 2015 | $232,394,000 | +52.4% | 3,286,470 | +91.5% | 0.19% | +51.6% |
| Q1 2015 | $152,518,000 | +49.4% | 1,716,578 | +49.1% | 0.13% | +44.8% |
| Q4 2014 | $102,066,000 | +4.7% | 1,151,202 | +14.5% | 0.09% | -2.2% |
| Q3 2014 | $97,487,000 | +15.3% | 1,005,855 | +9.3% | 0.09% | +15.6% |
| Q2 2014 | $84,520,000 | – | 920,097 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GAGNON SECURITIES LLC | 563,415 | $21,753,453 | 4.80% |
| Gagnon Advisors, LLC | 180,331 | $6,962,579 | 4.70% |
| Spyglass Capital Management LLC | 868,686 | $33,539,966 | 2.69% |
| Tamarack Advisers, LP | 100,000 | $3,861,000 | 1.99% |
| ARMISTICE CAPITAL, LLC | 1,892,000 | $73,050,120 | 1.27% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 276,590 | $10,679,140 | 0.99% |
| RICE HALL JAMES & ASSOCIATES, LLC | 437,285 | $16,883,574 | 0.97% |
| Rock Springs Capital Management LP | 1,032,600 | $39,868,686 | 0.96% |
| OUTFITTER FINANCIAL LLC | 25,860 | $998,455 | 0.91% |
| Stephens Investment Management Group LLC | 1,168,469 | $45,535,237 | 0.82% |